Do you think Beam Therapeutics (BEAM) is an undervalued stock?
Contrarius Investment Management, an investment management firm, released its third quarter investor letter for the “Contrarius Global Equity Fund.” A copy of the letter can be downloaded here. The fund’s investor class returned 30.9% in the September quarter, compared with 7.3% for the MSCI World benchmark, including net income reinvested, and 5.5% for the Average…